Sanofi Plavix Patent On Polymorphic Form Covers Currently Marketed Product
Executive Summary
Sanofi-Synthelabo's latest patent for its antithrombotic Plavix covers the polymorphic form of clopidogrel that is currently marketed in the U.S., the company said
You may also be interested in...
Bristol Prepares For Life After Pravachol: Support Will Continue Into 2005
Bristol-Myers Squibb will continue to promote Pravachol over the near term despite declining sales for the statin as wholesalers prepare for generic competition in 2006
Bristol Prepares For Life After Pravachol: Support Will Continue Into 2005
Bristol-Myers Squibb will continue to promote Pravachol over the near term despite declining sales for the statin as wholesalers prepare for generic competition in 2006
Bristol Earnings Feature Downside Disclosures But Still Rely On Restructuring
Bristol is signaling another round of restructuring for the end of 2003 as it prepares for the next wave of patent expirations